Cargando…

Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial

PURPOSE: In terms of medical policy for cervical cancer prevention, Japan lags far behind other industrialized countries. We initiated a randomized controlled trial to evaluate the self-sampling human papillomavirus (HPV) test as a tool to raise screening uptake and detection of pre-cancer. This stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujita, Misuzu, Nagashima, Kengo, Shimazu, Minobu, Suzuki, Misae, Tauchi, Ichiro, Sakuma, Miwa, Yamamoto, Setsuko, Hanaoka, Hideki, Shozu, Makio, Tsuruoka, Nobuhide, Kasai, Tokuzo, Hata, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249862/
https://www.ncbi.nlm.nih.gov/pubmed/37289798
http://dx.doi.org/10.1371/journal.pone.0286909
_version_ 1785055635233046528
author Fujita, Misuzu
Nagashima, Kengo
Shimazu, Minobu
Suzuki, Misae
Tauchi, Ichiro
Sakuma, Miwa
Yamamoto, Setsuko
Hanaoka, Hideki
Shozu, Makio
Tsuruoka, Nobuhide
Kasai, Tokuzo
Hata, Akira
author_facet Fujita, Misuzu
Nagashima, Kengo
Shimazu, Minobu
Suzuki, Misae
Tauchi, Ichiro
Sakuma, Miwa
Yamamoto, Setsuko
Hanaoka, Hideki
Shozu, Makio
Tsuruoka, Nobuhide
Kasai, Tokuzo
Hata, Akira
author_sort Fujita, Misuzu
collection PubMed
description PURPOSE: In terms of medical policy for cervical cancer prevention, Japan lags far behind other industrialized countries. We initiated a randomized controlled trial to evaluate the self-sampling human papillomavirus (HPV) test as a tool to raise screening uptake and detection of pre-cancer. This study was conducted to explore the acceptability and preference of self-sampling using a subset of the data from this trial. METHODS: A pre-invitation letter was sent to eligible women, aged 30−59 years who had not undergone cervical cancer screening for three or more years. After excluding those who declined to participate in this trial, the remaining women were assigned to the self-sampling and control groups. A second invitation letter was sent to the former group, and those wanting to undergo the self-sampling test ordered the kit. A self-sampling HPV kit, consent form, and a self-administered questionnaire were sent to participants who ordered the test. RESULTS: Of the 7,340 participants in the self-sampling group, 1,196 (16.3%) administered the test, and 1,192 (99.7%) answered the questionnaire. Acceptability of the test was favorable; 75.3−81.3% of participants agreed with positive impressions (easy, convenient, and clarity of instruction), and 65.1−77.8% disagreed with negative impressions (painful, uncomfortable, and embarrassing). However, only 21.2% were confident in their sampling procedure. Willingness to undergo screening with a self-collected sample was significantly higher than that with a doctor-collected sample (89.3% vs. 49.1%; p<0.001). Willingness to undergo screening with a doctor-collected sample was inversely associated with age and duration without screening (both p<0.001), but that with a self-collected sample was not associated. CONCLUSIONS: Among women who used the self-sampling HPV test, high acceptability was confirmed, while concerns about self-sampling procedures remained. Screening with a self-collected sample was preferred over a doctor-collected sample and the former might alleviate disparities in screening rates.
format Online
Article
Text
id pubmed-10249862
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-102498622023-06-09 Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial Fujita, Misuzu Nagashima, Kengo Shimazu, Minobu Suzuki, Misae Tauchi, Ichiro Sakuma, Miwa Yamamoto, Setsuko Hanaoka, Hideki Shozu, Makio Tsuruoka, Nobuhide Kasai, Tokuzo Hata, Akira PLoS One Research Article PURPOSE: In terms of medical policy for cervical cancer prevention, Japan lags far behind other industrialized countries. We initiated a randomized controlled trial to evaluate the self-sampling human papillomavirus (HPV) test as a tool to raise screening uptake and detection of pre-cancer. This study was conducted to explore the acceptability and preference of self-sampling using a subset of the data from this trial. METHODS: A pre-invitation letter was sent to eligible women, aged 30−59 years who had not undergone cervical cancer screening for three or more years. After excluding those who declined to participate in this trial, the remaining women were assigned to the self-sampling and control groups. A second invitation letter was sent to the former group, and those wanting to undergo the self-sampling test ordered the kit. A self-sampling HPV kit, consent form, and a self-administered questionnaire were sent to participants who ordered the test. RESULTS: Of the 7,340 participants in the self-sampling group, 1,196 (16.3%) administered the test, and 1,192 (99.7%) answered the questionnaire. Acceptability of the test was favorable; 75.3−81.3% of participants agreed with positive impressions (easy, convenient, and clarity of instruction), and 65.1−77.8% disagreed with negative impressions (painful, uncomfortable, and embarrassing). However, only 21.2% were confident in their sampling procedure. Willingness to undergo screening with a self-collected sample was significantly higher than that with a doctor-collected sample (89.3% vs. 49.1%; p<0.001). Willingness to undergo screening with a doctor-collected sample was inversely associated with age and duration without screening (both p<0.001), but that with a self-collected sample was not associated. CONCLUSIONS: Among women who used the self-sampling HPV test, high acceptability was confirmed, while concerns about self-sampling procedures remained. Screening with a self-collected sample was preferred over a doctor-collected sample and the former might alleviate disparities in screening rates. Public Library of Science 2023-06-08 /pmc/articles/PMC10249862/ /pubmed/37289798 http://dx.doi.org/10.1371/journal.pone.0286909 Text en © 2023 Fujita et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Fujita, Misuzu
Nagashima, Kengo
Shimazu, Minobu
Suzuki, Misae
Tauchi, Ichiro
Sakuma, Miwa
Yamamoto, Setsuko
Hanaoka, Hideki
Shozu, Makio
Tsuruoka, Nobuhide
Kasai, Tokuzo
Hata, Akira
Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial
title Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial
title_full Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial
title_fullStr Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial
title_full_unstemmed Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial
title_short Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial
title_sort acceptability of self-sampling human papillomavirus test for cervical cancer screening in japan: a questionnaire survey in the access trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249862/
https://www.ncbi.nlm.nih.gov/pubmed/37289798
http://dx.doi.org/10.1371/journal.pone.0286909
work_keys_str_mv AT fujitamisuzu acceptabilityofselfsamplinghumanpapillomavirustestforcervicalcancerscreeninginjapanaquestionnairesurveyintheaccesstrial
AT nagashimakengo acceptabilityofselfsamplinghumanpapillomavirustestforcervicalcancerscreeninginjapanaquestionnairesurveyintheaccesstrial
AT shimazuminobu acceptabilityofselfsamplinghumanpapillomavirustestforcervicalcancerscreeninginjapanaquestionnairesurveyintheaccesstrial
AT suzukimisae acceptabilityofselfsamplinghumanpapillomavirustestforcervicalcancerscreeninginjapanaquestionnairesurveyintheaccesstrial
AT tauchiichiro acceptabilityofselfsamplinghumanpapillomavirustestforcervicalcancerscreeninginjapanaquestionnairesurveyintheaccesstrial
AT sakumamiwa acceptabilityofselfsamplinghumanpapillomavirustestforcervicalcancerscreeninginjapanaquestionnairesurveyintheaccesstrial
AT yamamotosetsuko acceptabilityofselfsamplinghumanpapillomavirustestforcervicalcancerscreeninginjapanaquestionnairesurveyintheaccesstrial
AT hanaokahideki acceptabilityofselfsamplinghumanpapillomavirustestforcervicalcancerscreeninginjapanaquestionnairesurveyintheaccesstrial
AT shozumakio acceptabilityofselfsamplinghumanpapillomavirustestforcervicalcancerscreeninginjapanaquestionnairesurveyintheaccesstrial
AT tsuruokanobuhide acceptabilityofselfsamplinghumanpapillomavirustestforcervicalcancerscreeninginjapanaquestionnairesurveyintheaccesstrial
AT kasaitokuzo acceptabilityofselfsamplinghumanpapillomavirustestforcervicalcancerscreeninginjapanaquestionnairesurveyintheaccesstrial
AT hataakira acceptabilityofselfsamplinghumanpapillomavirustestforcervicalcancerscreeninginjapanaquestionnairesurveyintheaccesstrial